3 growing heath care stocks you need on your watch list

A growing industry and growing companies makes for a healthy investment combination.

a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The attraction of investing in the health care sector is obvious and investors need only look at a chart of stocks such as CSL Limited (ASX: CSL) and Ramsay Health Care Limited (ASX: RHC) – which have produced share price gains of 819% and 735% respectively – to realise that the sector is home to some outstanding businesses with brilliant growth prospects.

The "catch" for investors is that the high quality businesses and growth profiles of the likes of CSL and Ramsay is blindingly obvious! As a result many health care stocks trade with hefty premiums in acknowledgement of that fact. However with careful selection and understanding of the earnings growth potential of certain companies, there could still be opportunities for investors today with the following three stocks worth keeping an eye on.

1)      ResMed Inc. (CHESS) (ASX: RMD) offers investors exposure to the fast growing sleep apnea market. There is believed to be an enormous undiagnosed percentage of the population suffering from this condition. As one of the world's leading providers of breathing treatments for sleep apnea, ResMed is well positioned to continue its impressive track record of growth.

2)      Cochlear Limited (ASX: COH) also operates in the medical device segment like ResMed, however its products treat hearing impairment. While its cochlear implant products for treating profound deafness in children are well known, perhaps less widely understood is that Cochlear also provides hearing solutions to adults. An ageing population and more importantly a growing global middle class should see Cochlear's sales revenue continue its long-term growth trend.

3)      Virtus Health Ltd (ASX: VRT) has been one of the most successful initial public offerings (IPOs) of the past year. The company recently announced the acquisition of Ireland's largest IVF provider which gives it not only a strong foothold in Australia, but also Ireland and with the potential to expand into the UK. The soon to be floated Monash IVF Group Ltd (ASX: MVF) which is expected to list on June 25 will add further depth to this sector for investors.

Motley Fool contributor Tim McArthur does not own shares in any of the companies mentioned in this article.

More on ⏸️ Investing

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »

⏸️ Investing

Why Fox (NASDAQ:FOX) might hurt News Corp (ASX:NWS) shareholders

News Corporation (ASX: NWS) might be facing some existential threats from its American cousins over the riots on 6 January

Read more »